ProCE Banner Activity

E1505: Similar Survival Across 4 Different Chemotherapy Regimens in Early-Stage, Resected NSCLC

Slideset Download
Conference Coverage
DFS and OS outcomes similar in patients with early-stage, resected NSCLC for 4 different cisplatin-based doublet chemotherapy regimens tested.

Released: June 08, 2016

Expiration: June 07, 2017

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

This activity is supported by educational grants from

Amgen, Inc.

Ariad

Bayer Healthcare Pharma

Celgene

Genentech Roche Virology

Incyte

Merck Oncology

Taiho Pharmaceuticals